Cargando…
Bayesian estimation of SARS-CoV-2 prevalence in Indiana by random testing
From 25 to 29 April 2020, the state of Indiana undertook testing of 3,658 randomly chosen state residents for the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, the agent causing COVID-19 disease. This was the first statewide randomized study of COVID-19 testing in the Uni...
Autores principales: | Yiannoutsos, Constantin T., Halverson, Paul K., Menachemi, Nir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865174/ https://www.ncbi.nlm.nih.gov/pubmed/33441450 http://dx.doi.org/10.1073/pnas.2013906118 |
Ejemplares similares
-
Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample — Indiana, April 25–29, 2020
por: Menachemi, Nir, et al.
Publicado: (2020) -
Successive Wave Analysis to Assess Nonresponse Bias in a Statewide Random Sample Testing Study for SARS-CoV-2
por: Duszynski, Thomas J., et al.
Publicado: (2022) -
Association of Health Status and Nicotine Consumption with SARS-CoV-2 positivity rates
por: Duszynski, Thomas J., et al.
Publicado: (2021) -
Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study
por: Dixon, Brian E., et al.
Publicado: (2020) -
Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study
por: Dixon, Brian E., et al.
Publicado: (2021)